Cargando…
The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo
Vascular endothelial growth factor (VEGF) is known to occur as at least six differentially spliced variants, giving rise to mature isoforms containing 121, 145, 165, 183, 189 and 206 amino acids. However, little is yet known concerning the in vivo activities of this differential splicing. Stably tra...
Autores principales: | Zhang, H-T, Scott, P A E, Morbidelli, L, Peak, S, Moore, J, Turley, H, Harris, A L, Ziche, M, Bicknell, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374542/ https://www.ncbi.nlm.nih.gov/pubmed/10883669 http://dx.doi.org/10.1054/bjoc.2000.1279 |
Ejemplares similares
-
VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo
por: Rennel, E S, et al.
Publicado: (2009) -
NONO and tumorigenesis: More than splicing
por: Feng, Peifu, et al.
Publicado: (2020) -
Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic humaneratinocytes
por: Baumann, P, et al.
Publicado: (2000) -
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents
por: Morbidelli, Lucia, et al.
Publicado: (2016) -
Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma
por: Wang, G L, et al.
Publicado: (1999)